YOU ARE HERE:
Treatment interruptions news
page  of 3
 
Headline
Date
  Studies finds risks in guided treatment interruptions even at higher CD4 cell threshold
01.02.07
  Asthma drug provides effective treatment for immune reconstitution inflammatory syndrome
31.01.07
  One-in-six interrupt treatment within two years of initiating ART
18.09.06
  SMART study - treatment breaks lower quality of life
28.08.06
  New data shed light on poor outcome in SMART study
17.08.06
  Staccato study suggests that some CD4-guided treatment interruptions can be safe
08.08.06
  Study concludes that interleukin-2 has no benefit before HIV treatment interruptions, but increases side-effects
12.06.06
  Variation in gene linked to risk of resistance after stopping efavirenz treatment
10.04.06
  Treatment interruption arm of DART study halted
15.03.06
  CROI: Low rates of resistance seen in Staccato trial of CD4-guided treatment interruptions
27.02.06
  CROI News Feature: Experts divided over the future of treatment interruptions
10.02.06
  CROI: CD4-guided treatment interruptions unsafe, SMART study concludes
08.02.06
  Treatment interruption study stopped after excess number of AIDS events seen in people taking treatment breaks
11.01.06
  ICAAC: Viral load between six to 18 months predicts longer-term success of HIV therapy
05.01.06
  CD4 cell count below 250 associated with shorter treatment break
20.10.05
  Efavirenz may linger for up to eight weeks after treatment stops
28.09.05
  NNRTIs have a greater risk of resistance than PIs when used in regimens after treatment break
26.08.05
  IAS: Remune slows viral load rise and CD4 cell count fall during treatment interruptions
29.07.05
  Tenofovir may linger up to 3 weeks in body: discontinue with caution
14.06.05
  Travelling on HAART, particularly to the US, a 'negative practical and emotional experience.'
27.04.05

page  of 3